Anjali Aggarwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anjali Aggarwal has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Daisy Sahni
Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India
17 shared publications- Tulika Gupta
Department of Anatomy, Postgraduate Institute of Medical Education and Research, Chandigarh, India
11 shared publications - Vinit Sharma
Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
10 shared publications - Daisy Sahni
Department of Anatomy Postgraduate Institute of Medical Education and Research Chandigarh India
9 shared publications - Justin Jacob
Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
6 shared publications Vinit Sharma
Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
5 shared publications
Latest Publications
- Open Access
- 21 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (7) , 857-860
Subdeltoid ultrasound-guided brachial plexus block: A technical description with anatomical correlation and a preliminary case series
Regional anaesthesia in the emergency department requires reliable techniques with minimal complications. We describe a subdeltoid ultrasound-guided brachial plexus approach targeting a potential “nerve funnel” at the surgical neck of the humerus, bridging infraclavicular and axillary approaches. Cadaveric dissection explored its anatomical basis and correlated it with clinical sonographic findings. This retrospective case series included six adult patients with traumatic upper-limb injuries. Cadaveric observations suggested terminal nerve clustering and proximity of the musculocutaneous and intercostobrachial nerves at the subdeltoid level. All patients achieved adequate anaesthesia with a single 15 mL injection of 0.5% bupivacaine with 4 mg dexamethasone. The mean pain-free duration was 17.3 hours, with consistent tourniquet tolerance and no procedural complications. The subdeltoid approach appears feasible as a single-injection technique for upper-limb procedures. Using a superficial acoustic window and favourable anatomical clustering, it may provide effective coverage with technical simplicity. These preliminary findings require validation in larger prospective studies.
- 21 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (7) , 857-860
Open AccessSubdeltoid ultrasound-guided brachial plexus block: A technical description with anatomical correlation and a preliminary case series
Regional anaesthesia in the emergency department requires reliable techniques with minimal complications. We describe a subdeltoid ultrasound-guided brachial plexus approach targeting a potential “nerve funnel” at the surgical neck of the humerus, bridging infraclavicular and axillary approaches. Cadaveric dissection explored its anatomical basis and correlated it with clinical sonographic findings. This retrospective case series included six adult patients with traumatic upper-limb injuries. Cadaveric observations suggested terminal nerve clustering and proximity of the musculocutaneous and intercostobrachial nerves at the subdeltoid level. All patients achieved adequate anaesthesia with a single 15 mL injection of 0.5% bupivacaine with 4 mg dexamethasone. The mean pain-free duration was 17.3 hours, with consistent tourniquet tolerance and no procedural complications. The subdeltoid approach appears feasible as a single-injection technique for upper-limb procedures. Using a superficial acoustic window and favourable anatomical clustering, it may provide effective coverage with technical simplicity. These preliminary findings require validation in larger prospective studies.
- 14 July 2026
- Published by Elsevier in Cellular Immunology
- Vol. 427, 105131
Elevated neutrophil extracellular traps as potential diagnostic biomarkers in pancreatic ductal adenocarcinoma
- 14 July 2026
- Published by Elsevier in Cellular Immunology
- Vol. 427, 105131
Elevated neutrophil extracellular traps as potential diagnostic biomarkers in pancreatic ductal adenocarcinoma
- 7 July 2026
- Published by Wiley in Clinical Anatomy
Aging Induced Senescence of Human Cardiac Progenitor Cells Alters the Healthy Cellular Microenvironment: Implications for Cell‐Based Therapy
Age‐related senescence can profoundly alter the physiology and therapeutic potential of cardiac progenitor cells (CPCs), thus undermining the efficiency of cell‐based therapies for treatment of various cardiovascular diseases. In this study, CPCs were isolated from right atrial appendage tissue obtained during open heart surgery from patients: younger (< 30 years, n = 10) and elderly (> 60 years, n = 10). Phenotypic and functional characterization of CPCs was done along with evaluation of age‐related senescent changes using various assays. CPCs derived from elderly patients exhibited significantly reduced proliferative potential, enlarged morphology, increased expression of senescence markers (p16 Ink4A , SA β‐gal, γH2AX), and significantly higher proportion of cells in the G0/G1 phase of the cell cycle. In addition, aged CPCs showed elevated secretion of senescence associated secretory phenotypes (SASP) factors, particularly IL‐8, IL‐10, and IFN‐γ. Current study observed that a significantly higher (80%) number of CPCs among the older population were senescent, dysfunctional, and in the resting phase of the cell cycle, thus having limited ability to repair the damaged heart. Further, we observed a contradictory increase in Nkx2.5 expression with age, suggesting the reactivation of the cardiac Nkx2.5 enhancer.
- 7 July 2026
- Published by Wiley in Clinical Anatomy
Aging Induced Senescence of Human Cardiac Progenitor Cells Alters the Healthy Cellular Microenvironment: Implications for Cell‐Based Therapy
Age‐related senescence can profoundly alter the physiology and therapeutic potential of cardiac progenitor cells (CPCs), thus undermining the efficiency of cell‐based therapies for treatment of various cardiovascular diseases. In this study, CPCs were isolated from right atrial appendage tissue obtained during open heart surgery from patients: younger (< 30 years, n = 10) and elderly (> 60 years, n = 10). Phenotypic and functional characterization of CPCs was done along with evaluation of age‐related senescent changes using various assays. CPCs derived from elderly patients exhibited significantly reduced proliferative potential, enlarged morphology, increased expression of senescence markers (p16 Ink4A , SA β‐gal, γH2AX), and significantly higher proportion of cells in the G0/G1 phase of the cell cycle. In addition, aged CPCs showed elevated secretion of senescence associated secretory phenotypes (SASP) factors, particularly IL‐8, IL‐10, and IFN‐γ. Current study observed that a significantly higher (80%) number of CPCs among the older population were senescent, dysfunctional, and in the resting phase of the cell cycle, thus having limited ability to repair the damaged heart. Further, we observed a contradictory increase in Nkx2.5 expression with age, suggesting the reactivation of the cardiac Nkx2.5 enhancer.
- 1 May 2026
- Published by Springer Nature
- p. 39-77
Synergistic Potential of Phytochemicals and Immune Checkpoint Inhibitors in Gastrointestinal Cancer Therapy
- 1 May 2026
- Published by Springer Nature
- p. 39-77
Synergistic Potential of Phytochemicals and Immune Checkpoint Inhibitors in Gastrointestinal Cancer Therapy
- 16 February 2026
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 48 (1) , 69
Anatomical relationship of the suprascapular and axillary nerves to the glenohumeral joint and its surgical significance: a systematic review
The suprascapular (SSN) and axillary (AXN) nerves are vital for shoulder mobility and are at notable risk for injury during glenohumeral surgeries due to their proximity to key anatomical landmarks. This systematic review evaluates their anatomical positioning relative to the glenohumeral joint and highlights the clinical significance of these relationships in shoulder procedures. A thorough literature search across PubMed, MEDLINE, and Google Scholar (2018-2025) yielded 424 studies. After applying inclusion criteria, 21 articles-including clinical, cadaveric, and systematic reviews-were selected to assess nerve pathways, anatomical variations, injury rates, and surgical relevance. The pooled incidence of SSN injury was 0.03 (95% CI: 0.00-0.08), indicating an extremely low occurrence across studies. In contrast, the pooled incidence of AXN injury was 0.07 (4%) [95% CI: 0.01-0.18], reflecting a higher but still uncommon risk. Meta-regression showed a significant association between longer follow-up duration and increased reporting of AXN injuries (p = 0.0005), whereas this relationship was not significant for SSN injuries (p = 0.3612). Significant publication bias was detected for both nerves (AXN: p = 0.0016; SSN: p < 0.0001). Overall, AXN injuries occurred in approximately 1% of cases-more frequent than SSN injuries, which were nearly absent in pooled analysis. Anatomical variability in the SSN and AXN significantly influences the likelihood of nerve injury during shoulder surgery. Utilizing preoperative imaging, tailoring surgical approaches to individual anatomy, and employing intraoperative nerve monitoring are essential strategies for minimising nerve damage. Enhanced anatomical education-through cadaveric dissection and surgical simulation-should be emphasised to reinforce knowledge. These findings support adopting nerve-sparing, patient-specific surgical techniques to improve safety and outcomes in shoulder procedures.
- 16 February 2026
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 48 (1) , 69
Anatomical relationship of the suprascapular and axillary nerves to the glenohumeral joint and its surgical significance: a systematic review
The suprascapular (SSN) and axillary (AXN) nerves are vital for shoulder mobility and are at notable risk for injury during glenohumeral surgeries due to their proximity to key anatomical landmarks. This systematic review evaluates their anatomical positioning relative to the glenohumeral joint and highlights the clinical significance of these relationships in shoulder procedures. A thorough literature search across PubMed, MEDLINE, and Google Scholar (2018-2025) yielded 424 studies. After applying inclusion criteria, 21 articles-including clinical, cadaveric, and systematic reviews-were selected to assess nerve pathways, anatomical variations, injury rates, and surgical relevance. The pooled incidence of SSN injury was 0.03 (95% CI: 0.00-0.08), indicating an extremely low occurrence across studies. In contrast, the pooled incidence of AXN injury was 0.07 (4%) [95% CI: 0.01-0.18], reflecting a higher but still uncommon risk. Meta-regression showed a significant association between longer follow-up duration and increased reporting of AXN injuries (p = 0.0005), whereas this relationship was not significant for SSN injuries (p = 0.3612). Significant publication bias was detected for both nerves (AXN: p = 0.0016; SSN: p < 0.0001). Overall, AXN injuries occurred in approximately 1% of cases-more frequent than SSN injuries, which were nearly absent in pooled analysis. Anatomical variability in the SSN and AXN significantly influences the likelihood of nerve injury during shoulder surgery. Utilizing preoperative imaging, tailoring surgical approaches to individual anatomy, and employing intraoperative nerve monitoring are essential strategies for minimising nerve damage. Enhanced anatomical education-through cadaveric dissection and surgical simulation-should be emphasised to reinforce knowledge. These findings support adopting nerve-sparing, patient-specific surgical techniques to improve safety and outcomes in shoulder procedures.
- 14 November 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_13) , 142
AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELL THERAPY COMBINED WITH CORE DECOMPRESSION HAS BETTER OUTCOME THAN CORE DECOMPRESSION ALONE FOR EARLY-STAGE OSTEONECROSIS OF FEMORAL HEAD
Osteonecrosis of femur head is a chronic progressive, debilitating and painful disease of hip joint characterized by the progressive necrosis of osteogenic cells. Disease progression commonly leads to collapse of the affected femur head and ultimately development of osteoarthritis. Improved understanding of healing logistics and orthobiologics has provided a ray of hope for treating osteonecrosis of femoral head. Purpose was to evaluate efficacy of autologous bone marrow derived mesenchymal cells (BM-MSC) augmentation during core decompression vis–a–vis core decompression in early stages of osteonecrosis. 38 (50 hips) were randomized into Group A BM-MSC with core decompression (18/26 hips) and group B (core decompression only (20/24 hips). Bone marrow aspirated from the posterior superior iliac spine was centrifuged. Mean 153.91 million (SD= 91.30) number of BM-MSC harvested were instilled into the core decompression tracts of patients in group A. Outcome was evaluated in terms of VAS, Harris Hip score (HHS) and modified Kerboul angle for quantification of necrotic area using magnetic resonance imaging. Follow up ranged from 4-14 (mean: 8.8) months. Aetiology of osteonecrosis was alcohol consumption (47.3%), steroid use (34.2%) and idiopathic(18.4%). The patients were predominantly male (94.7%) with age ranging from 18–65 years (average age 37.01 years). VAS scores improved from pre-operative levels of 5.45±1.46 to 1.33±.97 in group A. VAS scores in group B increased from 5.45±0.51 to 2.88±.69. The HHS in group A had a final mean value of 80.9±14.5 from a baseline score of 61.3±16.9. In group B the HHS changed from a baseline score of 67.6±9.3 to 72.4±7.4. Statistically significant improvement in VAS (p value 0.017), HHS (p value 0.00) and modified Kerboul angle was observed in group A as compared to group B. Modified Kerboul angle changed by a mean of 4.1±15.4 in group A and 21.0±23.8 in group B. There was statistically significant change and progression of disease in group B. There was progression of disease in 3 hips of group A and 5 hips of group B. Negative correlation between change in angle and HHS was observed at final follow up.No intraoperative and postoperative complications were observed. Addition of autologous bone marrow derived mesenchymal stem cells have better clinical improvement than isolated core decompression for early stages of osteonecrosis of femur head.
- 14 November 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_13) , 142
AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELL THERAPY COMBINED WITH CORE DECOMPRESSION HAS BETTER OUTCOME THAN CORE DECOMPRESSION ALONE FOR EARLY-STAGE OSTEONECROSIS OF FEMORAL HEAD
Osteonecrosis of femur head is a chronic progressive, debilitating and painful disease of hip joint characterized by the progressive necrosis of osteogenic cells. Disease progression commonly leads to collapse of the affected femur head and ultimately development of osteoarthritis. Improved understanding of healing logistics and orthobiologics has provided a ray of hope for treating osteonecrosis of femoral head. Purpose was to evaluate efficacy of autologous bone marrow derived mesenchymal cells (BM-MSC) augmentation during core decompression vis–a–vis core decompression in early stages of osteonecrosis. 38 (50 hips) were randomized into Group A BM-MSC with core decompression (18/26 hips) and group B (core decompression only (20/24 hips). Bone marrow aspirated from the posterior superior iliac spine was centrifuged. Mean 153.91 million (SD= 91.30) number of BM-MSC harvested were instilled into the core decompression tracts of patients in group A. Outcome was evaluated in terms of VAS, Harris Hip score (HHS) and modified Kerboul angle for quantification of necrotic area using magnetic resonance imaging. Follow up ranged from 4-14 (mean: 8.8) months. Aetiology of osteonecrosis was alcohol consumption (47.3%), steroid use (34.2%) and idiopathic(18.4%). The patients were predominantly male (94.7%) with age ranging from 18–65 years (average age 37.01 years). VAS scores improved from pre-operative levels of 5.45±1.46 to 1.33±.97 in group A. VAS scores in group B increased from 5.45±0.51 to 2.88±.69. The HHS in group A had a final mean value of 80.9±14.5 from a baseline score of 61.3±16.9. In group B the HHS changed from a baseline score of 67.6±9.3 to 72.4±7.4. Statistically significant improvement in VAS (p value 0.017), HHS (p value 0.00) and modified Kerboul angle was observed in group A as compared to group B. Modified Kerboul angle changed by a mean of 4.1±15.4 in group A and 21.0±23.8 in group B. There was statistically significant change and progression of disease in group B. There was progression of disease in 3 hips of group A and 5 hips of group B. Negative correlation between change in angle and HHS was observed at final follow up.No intraoperative and postoperative complications were observed. Addition of autologous bone marrow derived mesenchymal stem cells have better clinical improvement than isolated core decompression for early stages of osteonecrosis of femur head.
- Open Access
- 26 September 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-14
Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer
Aim Pancreatic cancer (PC) is marked by high mortality and resistance to conventional therapies, largely due to a dense desmoplastic stroma that promotes drug resistance and metastasis. This highlights the need for specific non-invasive diagnostic markers. MicroRNAs (miRNAs), known for regulating gene expression and influencing tumor behavior, have emerged as promising biomarkers. This study aimed to evaluate the expression of circulating miR-6875 and miR-1307 in PC patients to explore their diagnostic potential. Methods Blood, urine, and saliva samples were collected from 20 PC patients and 12 healthy controls. RNA extraction and cDNA synthesis were performed following standard protocols, and quantitative real-time PCR assays were used to quantify miR-6875 and miR-1307 expression levels. Statistical analysis was performed to predict their diagnostic potential and association with clinical and biochemical parameters of PC patients. Results Our results revealed significantly elevated levels of miR-6875 and miR-1307 in plasma, urine samples, and saliva samples from PC patients compared to controls. Receiver operating characteristic (ROC) curve analysis demonstrated the potential of miR-6875 and miR-1307 in plasma as diagnostic biomarkers for PC, with AUC values of 0.79 and 0.83, respectively. Conclusion Plasma levels of miR-6875 and miR-1307 show potential as non-invasive diagnostic biomarkers for pancreatic cancer.
- 26 September 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-14
Open AccessPotential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer
Aim Pancreatic cancer (PC) is marked by high mortality and resistance to conventional therapies, largely due to a dense desmoplastic stroma that promotes drug resistance and metastasis. This highlights the need for specific non-invasive diagnostic markers. MicroRNAs (miRNAs), known for regulating gene expression and influencing tumor behavior, have emerged as promising biomarkers. This study aimed to evaluate the expression of circulating miR-6875 and miR-1307 in PC patients to explore their diagnostic potential. Methods Blood, urine, and saliva samples were collected from 20 PC patients and 12 healthy controls. RNA extraction and cDNA synthesis were performed following standard protocols, and quantitative real-time PCR assays were used to quantify miR-6875 and miR-1307 expression levels. Statistical analysis was performed to predict their diagnostic potential and association with clinical and biochemical parameters of PC patients. Results Our results revealed significantly elevated levels of miR-6875 and miR-1307 in plasma, urine samples, and saliva samples from PC patients compared to controls. Receiver operating characteristic (ROC) curve analysis demonstrated the potential of miR-6875 and miR-1307 in plasma as diagnostic biomarkers for PC, with AUC values of 0.79 and 0.83, respectively. Conclusion Plasma levels of miR-6875 and miR-1307 show potential as non-invasive diagnostic biomarkers for pancreatic cancer.
- 12 September 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (3) , 777-788
Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers
Gastrointestinal (GI) cancers represent a significant global health burden, accounting for over one-third of cancer-related deaths globally. Regardless of advancements in treatment procedures, the high mortality rate underscores the crucial need for novel diagnostic biomarkers and therapeutic strategies. Extracellular vesicles (EVs) appeared as fundamental facilitators of intercellular interaction, influencing gene expression as well as cellular function through the transfer of nucleic acids, proteins, and lipids. EVs play dual roles in maintaining intestinal homeostasis under physiological conditions and driving tumorigenesis in pathological states. In GI cancers, EVs contribute to tumor progression by modulating the tumor microenvironment (TME), promoting angiogenesis, epithelial-to-mesenchymal transition (EMT), immune evasion, and metastasis. Moreover, EVs portray a vital role in creating pre-metastatic site, reprogramming immune cells, and facilitating therapeutic resistance through the transfer of resistance-associated molecules. The clinical potential of EVs extends to their utility as liquid biopsy biomarkers, offering a non-invasive approach for early diagnosis, prognostication, and treatment monitoring. EV-miRNAs and EV-long non-coding RNAs demonstrate significant diagnostic and prognostic value in GI cancers. This review provides a widespread impression of the biogenesis, molecular properties, and functional roles of EVs in GI cancers, with a focus on their clinical utility.
- 12 September 2025
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (3) , 777-788
Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers
Gastrointestinal (GI) cancers represent a significant global health burden, accounting for over one-third of cancer-related deaths globally. Regardless of advancements in treatment procedures, the high mortality rate underscores the crucial need for novel diagnostic biomarkers and therapeutic strategies. Extracellular vesicles (EVs) appeared as fundamental facilitators of intercellular interaction, influencing gene expression as well as cellular function through the transfer of nucleic acids, proteins, and lipids. EVs play dual roles in maintaining intestinal homeostasis under physiological conditions and driving tumorigenesis in pathological states. In GI cancers, EVs contribute to tumor progression by modulating the tumor microenvironment (TME), promoting angiogenesis, epithelial-to-mesenchymal transition (EMT), immune evasion, and metastasis. Moreover, EVs portray a vital role in creating pre-metastatic site, reprogramming immune cells, and facilitating therapeutic resistance through the transfer of resistance-associated molecules. The clinical potential of EVs extends to their utility as liquid biopsy biomarkers, offering a non-invasive approach for early diagnosis, prognostication, and treatment monitoring. EV-miRNAs and EV-long non-coding RNAs demonstrate significant diagnostic and prognostic value in GI cancers. This review provides a widespread impression of the biogenesis, molecular properties, and functional roles of EVs in GI cancers, with a focus on their clinical utility.
- Open Access
- 8 August 2025
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 161 (6) , 742-747
Expression of circulating p38 inhibited cutaneous squamous cell carcinoma-associated long non-coding RNA in rheumatoid arthritis: A descriptive study
Background & objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint destruction. Long non-coding RNAs (lncRNAs) have emerged as key regulators in RA pathogenesis. This study explores the serum expression of p38-inhibited cutaneous squamous cell carcinoma-associated lncRNA (PICSAR lncRNA) as a potential non-invasive biomarker for RA. Methods: PICSAR lncRNA expression was measured in serum samples from 36 individuals with RA and 20 healthy individuals using qRT-PCR over a 24 h time course. Correlation analyses with demographic and biochemical parameters, American College of Rheumatology (ACR) scores, and ROC analysis were conducted to evaluate the diagnostic potential of PICSAR lncRNA. Results: We observed significant upregulation of PICSAR lncRNA in individuals with RA at 0 h (448.9±358.6, P=0.0059) and 6 h (202.0±121.2, P=0.0005) compared to healthy individuals, with stable levels maintained up to 24 h. The ROC analysis yielded a substantial AUC value of 0.74 for PICSAR lncRNA in individuals with RA. In females with RA, PICSAR lncRNA levels showed a positive correlation with ACR scores and a negative correlation with age. Interpretation & conclusions: PICSAR lncRNA is implicated in RA pathogenesis and may serve as a potential non-invasive diagnostic biomarker for RA.
- 8 August 2025
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 161 (6) , 742-747
Open AccessExpression of circulating p38 inhibited cutaneous squamous cell carcinoma-associated long non-coding RNA in rheumatoid arthritis: A descriptive study
Background & objectives: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint destruction. Long non-coding RNAs (lncRNAs) have emerged as key regulators in RA pathogenesis. This study explores the serum expression of p38-inhibited cutaneous squamous cell carcinoma-associated lncRNA (PICSAR lncRNA) as a potential non-invasive biomarker for RA. Methods: PICSAR lncRNA expression was measured in serum samples from 36 individuals with RA and 20 healthy individuals using qRT-PCR over a 24 h time course. Correlation analyses with demographic and biochemical parameters, American College of Rheumatology (ACR) scores, and ROC analysis were conducted to evaluate the diagnostic potential of PICSAR lncRNA. Results: We observed significant upregulation of PICSAR lncRNA in individuals with RA at 0 h (448.9±358.6, P=0.0059) and 6 h (202.0±121.2, P=0.0005) compared to healthy individuals, with stable levels maintained up to 24 h. The ROC analysis yielded a substantial AUC value of 0.74 for PICSAR lncRNA in individuals with RA. In females with RA, PICSAR lncRNA levels showed a positive correlation with ACR scores and a negative correlation with age. Interpretation & conclusions: PICSAR lncRNA is implicated in RA pathogenesis and may serve as a potential non-invasive diagnostic biomarker for RA.